University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)
About University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Clinical Trials at University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)
During the past decade, University of Michigan; Michigan Institute for Clinical and Health Research (MICHR) conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors
2014-05-21
2020-04-16
Completed
609
A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma
2017-12-11
2021-02-19
Terminated
446
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)
According to Clinical.Site data, the most researched conditions in "University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)" are
"Advanced BRAFV600 Wild-type Melanoma" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)" in a lesser frequency.
Clinical Trials Intervention Types at University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)
Most popular intervention types in "University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (1 trials), "Cobimetinib" (1 trials), "Etrozulimab" (1 trials), "Pembrolizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)
The vast majority of trials in "University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)" are
2 trials for "All" genders.
Clinical Trials Status at University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)
Currently, there are NaN active trials in "University of Michigan; Michigan Institute for Clinical and Health Research (MICHR)".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in University of Michigan; Michigan Institute for Clinical and Health Research (MICHR),
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Michigan; Michigan Institute for Clinical and Health Research (MICHR), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".